Corient Private Wealth
RNAM

Corient Private Wealth’s Avidity Biosciences RNAM Stock Holding History

Corient Private Wealth’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,100
Closed -$1.38M – 2997
2025
Q4 		$1.38M Buy
+19,100
New +$1.23M ﹤0.01% 1720
2025
Q3 		– Sell
-9,932
Closed -$282K – 2660
2025
Q2 		$282K Sell
9,932
-81
-0.8% -$2.41K ﹤0.01% 2024
2025
Q1 		$296K Sell
10,013
-512
-5% -$15.9K ﹤0.01% 1860
2024
Q4 		$306K Sell
10,525
-731
-6% -$30.5K ﹤0.01% 1882
2024
Q3 		$517K Sell
11,256
-14
-0.1% -$608 ﹤0.01% 1718
2024
Q2 		$460K Buy
11,270
+50
+0.4% +$1.44K ﹤0.01% 1694
2024
Q1 		$286K Hold
11,220
– – ﹤0.01% 1918
2023
Q4 		$102K Sell
11,220
-860
-7% -$5.75K ﹤0.01% 2156
2023
Q3 		$77.1K Buy
12,080
+1,389
+13% +$12K ﹤0.01% 2053
2023
Q2 		$119K Sell
10,691
-197
-2% -$2.47K ﹤0.01% 1953
2023
Q1 		$167K Hold
10,888
– – ﹤0.01% 1822
2022
Q4 		$242K Buy
+10,888
New +$162K ﹤0.01% 1417

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Corient Private Wealth's RNAM Position: Q1 2026 in Review

Corient Private Wealth sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 19,100 shares — an estimated $1.38M sold.

Corient Private Wealth first reported a position in RNAM in Q4 2022 and held it in 12 quarters. The position peaked at $1.38M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Corient Private Wealth reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Corient Private Wealth sold 19,100 Avidity Biosciences shares in Q1 2026, an estimated $1.38M.
  • Corient Private Wealth first reported a position in Avidity Biosciences in Q4 2022 and held it in 12 quarters.
  • Corient Private Wealth's Avidity Biosciences position peaked at $1.38M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.